Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalls Carisoprodol Tablets, USP, 350 mg, unit dose blister packages of 100 tablets (10 cards of 10 tablets each), Rx only, Man
Recalled March 19, 2014 · FDA recall D-1155-2014 · Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
Hazard
Failed Impurity/degradation Specification · FDA Class III
Units
3,252 cartons
Sold at
US: Nationwide
Description
Failed Impurity/degradation Specification
Product
Carisoprodol Tablets, USP, 350 mg, unit dose blister packages of 100 tablets (10 cards of 10 tablets each), Rx only, Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL NDC 51079-819-20
Manufacturer(s)
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →